Trending Medical and health breaking news Isatuximab Added to RVd Boosts Response in New Myeloma

Trending Medical and well being breaking information Isatuximab Added to RVd Boosts Response in New Myeloma

A new drug recently introduced for use in the treatment of refractory/relapsed multiple myeloma looks like it will also find a role in the treatment of patients with newly diagnosed transplant-eligible multiple myeloma. The drug is isatuximab (Sarclisa, Sanofi), an anti-CD38 antibody that was approved last year for use in patients with advanced disease. Now…